• Careers
  • News
  • Contact Us
Prasco.com Prasco.com
  • Who We Are
    • Who We Are
    • Our Culture
    • Company History
    • Leadership Team
  • What We Do
    • What We Do
    • Authorized Generics
    • Business Development
    • Sales
    • Commercialization Services
  • Products & Savings
    • Co-Pay Cards
    • Product List
    • Patient Assistance
Select Page
Launched Authorized Generic of Sprycel (Dasatinib)

Launched Authorized Generic of Sprycel (Dasatinib)

by Taylor Stump | Sep 1, 2024

Launched Authorized Generic of Sprycel (Dasatinib)

Launched Authorized Generic of Blockbusters Farxiga (Dapagliflozin) and Xigduo (Dapagliflozin/Metformin ER)

by scalewp | Apr 4, 2024

Launched Authorized Generic of Sprycel (Dasatinib)

Prasco acquires Independence Pharmaceuticals expanding CII portfolio with ProCentra (dextroamphetamine sulfate)

by scalewp | Apr 4, 2024

Launched Authorized Generic of Sprycel (Dasatinib)

Launched Authorized Generic of Blockbusters Flovent HFA (Fluticasone Propionate HFA Inhalation Aerosol) and Breo (Fluticasone Furoate/Vilanterol)

by scalewp | Apr 4, 2024

Launched Authorized Generic of Sprycel (Dasatinib)

Prasco expands portfolio through 1st Hampton Laine launch of Estradiol Cream

by scalewp | Apr 4, 2024

« Older Entries

Recent Posts

  • Authorized Generic of Farxiga® (Dapagliflozin) Tablets and Xigduo® (Dapagliflozin/Metformin) Extended-Release Tablets Available from Prasco
  • Prasco Launches Authorized Generic of ZIOPTAN® Ophthalmic Solution
  • Prasco Launches the Authorized Generic of NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)
  • Prasco Launches the Authorized Generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder)
  • Prasco Appoints VP of Trade Relations and New Chief Marketing Officer

Recent Comments

  • hello world on Authorized Generic of Farxiga® (Dapagliflozin) Tablets and Xigduo® (Dapagliflozin/Metformin) Extended-Release Tablets Available from Prasco
  • 92stargamedownload on Federal Trade Commission Reports: Authorized Generics, during the 180-day Exclusivity Period, Benefit Consumers and the American Healthcare System
  • ls168game on Federal Trade Commission Reports: Authorized Generics, during the 180-day Exclusivity Period, Benefit Consumers and the American Healthcare System
  • ls168gamedownload on Federal Trade Commission Reports: Authorized Generics, during the 180-day Exclusivity Period, Benefit Consumers and the American Healthcare System
  • gamespkdownload on Prasco to Market Authorized Generic of ZEGERID®

WHO WE ARE

Our Culture
Company History
Leadership Team

WHAT WE DO

Authorized Generics
Business Development
Sales
Commercialization Services

GET IN TOUCH

CUSTOMER SERVICE
Business Inquiries

Copyright © 2025 Prasco, LLC. All Rights Reserved. Privacy Policy. Terms of Use. Compliance.